Hear from Dr. Otis Johnson, Co-Founder of Trial Equity Group, as we explore the critical issue of patient diversity in clinical trials. Dr. Johnson discusses the alarming underrepresentation revealed in recent research, and shares how Trial Equity is addressing this gap. Join the conversation to uncover the impact of diverse recruitment on trial efficiency, the positive trends in technology, and the future of inclusive clinical research.